GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹64 Cr | ₹39 Cr | ₹40 Cr | ₹11 Cr | ₹0.63 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹64 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹0.63 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹64 Cr | 62.66 | |
Mar2023 | ₹39 Cr | -2.08 | |
Mar2022 | ₹40 Cr | 282.80 | |
Mar2021 | ₹11 Cr | 1,568.94 | |
Mar2020 | ₹0.63 Cr | - |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,904.9 Cr | -7.8% | 3.5% | 13.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -7.8% |
3.5% |
13.5% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses